According to BioXcel Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ1.62. In 2023 the company made an earnings per share (EPS) of -ยฃ4.62 a decrease over its 2022 EPS that were of -ยฃ4.44.